SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
原型病原体防范促进了SARS-CoV-2 mRNA疫苗的研发
期刊:
影响因子:
doi:10.1101/2020.06.11.145920
Corbett, Kizzmekia S; Edwards, Darin; Leist, Sarah R; Abiona, Olubukola M; Boyoglu-Barnum, Seyhan; Gillespie, Rebecca A; Himansu, Sunny; Schäfer, Alexandra; Ziwawo, Cynthia T; DiPiazza, Anthony T; Dinnon, Kenneth H; Elbashir, Sayda M; Shaw, Christine A; Woods, Angela; Fritch, Ethan J; Martinez, David R; Bock, Kevin W; Minai, Mahnaz; Nagata, Bianca M; Hutchinson, Geoffrey B; Bahl, Kapil; Garcia-Dominguez, Dario; Ma, LingZhi; Renzi, Isabella; Kong, Wing-Pui; Schmidt, Stephen D; Wang, Lingshu; Zhang, Yi; Stevens, Laura J; Phung, Emily; Chang, Lauren A; Loomis, Rebecca J; Altaras, Nedim Emil; Narayanan, Elisabeth; Metkar, Mihir; Presnyak, Vlad; Liu, Catherine; Louder, Mark K; Shi, Wei; Leung, Kwanyee; Yang, Eun Sung; West, Ande; Gully, Kendra L; Wang, Nianshuang; Wrapp, Daniel; Doria-Rose, Nicole A; Stewart-Jones, Guillaume; Bennett, Hamilton; Nason, Martha C; Ruckwardt, Tracy J; McLellan, Jason S; Denison, Mark R; Chappell, James D; Moore, Ian N; Morabito, Kaitlyn M; Mascola, John R; Baric, Ralph S; Carfi, Andrea; Graham, Barney S